Biotech Insight podcast: Overcoming planning challenges in oncologyThe first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges Share XBiotech Insight podcast: Overcoming planning challenges in oncologyhttps://pharmaphorum.com/podcast/biotech-insight-oncology-planning/
Vertex’s Nicola Massey: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager Share XVertex’s Nicola Massey: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/vertex-senior-country-manager-nicola-massey/
Organicell on regenerative medicine: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer Share XOrganicell on regenerative medicine: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/organicell-regenerative-medicine-covid/
Pharmacy and clinical research: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder Share XPharmacy and clinical research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharmacy-clinical-research-rxe2/
Pharma’s post-COVID prospects: the pharmaphorum podcastIn this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about Share XPharma’s post-COVID prospects: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharma-post-covid-prospects-accenture/
Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcastEpisode 35 of the pharmaphorum podcast hears from Michael Smyth about Galapagos UK and joining the company as Share XGalapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/galapago-uk-michael-smyth-rna/
Big data and cell therapy development: the pharmaphorum podcastIn the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who’s the Share XBig data and cell therapy development: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/mogrify-big-data-cell-therapy/
GSK on COVID and vaccine development: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and Share XGSK on COVID and vaccine development: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-covid-vaccines/
The meaning of digital innovation: the pharmaphorum podcastThis instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, Share XThe meaning of digital innovation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/digital-innovation-edwin-erckens-exeevo/
